Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

HPA-Axis Modulation

Also: Hypothalamic-Pituitary-Adrenal Axis · id HPA

Stress-response system; chronic dysregulation is associated with depression, anxiety, and inflammation. Adaptogenic plants are most often investigated here.

2 drugs act here5 plants reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on HPA-Axis Modulation

These medications have HPA-Axis Modulation among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on HPA-Axis Modulation

Each plant below contains a named compound documented to act on HPA-Axis Modulation. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Withanolide fractionsteroidal lactone

    Modulates the HPA axis (cortisol-lowering during stress) and exerts mild GABA-A modulation centrally. Together these underlie the documented anxiolytic and sleep-promoting effects.

  • Morinda officinalis oligosaccharides (MOO)Oligosaccharide / prebiotic

    Preclinical and clinical studies report that MOO is minimally absorbed systemically; proposed mechanism involves gut microbiota modulation of the tryptophan → 5-HTP → serotonin pathway, with downstream increases in central 5-HT and reported BDNF upregulation. MOO is an orally approved drug in China for depressive disorder.

  • Ocimumosides A & BPhenylpropanoid glycoside

    Adaptogenic glycosides specific to Tulsi; HPA-axis modulation contributes to stress effects.

  • Eleutherosides A–GMixed lignans / glycosides

    Heterogeneous group of compounds (taxonomically distinct from Panax ginsenosides). Primary adaptogenic constituents underlying Soviet-era 'tonic' research.

  • Steroidal saponins (shatavarins)

    Shatavari is a classical Ayurvedic adaptogen; preclinical work attributes HPA-axis/stress-response modulation to its steroidal saponins. Evidence is preliminary, but HPA modulation is the named adaptogenic mechanism rather than generic noise.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.